Phase II Trial of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma in Adults: A Multi-Center Trial
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary)
- Indications Ependymoma
- Focus Therapeutic Use
- 23 Oct 2015 Planned primary completion date changed from 1 Mar 2017 to 1 Jul 2018, as reported by ClinicalTrials.gov record.
- 12 Aug 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017, as reported by ClinicalTrials.gov.
- 24 Dec 2012 New source identified and integrated (Memorial Sloan-Kettering Cancer Center: 11-146).